A Phase 1 Study of Safety, Tolerability and Pharmacokinetics of Oral Single-Dose S-033188, a Novel Anti-influenza Agent, in Healthy Adult Male Subjects | Zendy

AI Assistant Blog Pricing

A Phase 1 Study of Safety, Tolerability and Pharmacokinetics of Oral Single-Dose S-033188, a Novel Anti-influenza Agent, in Healthy Adult Male Subjects

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.